INCB-099280

N/A

Report date: 2025/02/07 16:24:25
NME

Base Information

Drug NameINCB-099280
Drug Alias NameINCB-099280INCB-99280
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsSolid tumoursMicrosatellite instability-high cancerMismatch Repair Deficient Cancer +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[26] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesIncyte Corp Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIncyte Corp
Inactive CompaniesIncyte Biosciences (Shanghai) Co Ltd
Active IndicationsColorectal Neoplasms
Inactive IndicationsSolid tumoursMicrosatellite instability-high cancerMismatch Repair Deficient Cancer +[15] 

Other Information

ATC CodeN/A
Related LinksN/A